The Northwestern spinout is riding the IPO wave that's lifting biopharma companies. The stock begins trading today on the Nasdaq.
from nicholemhearn digest http://www.chicagobusiness.com/article/20180621/BLOGS11/180629971/drug-startup-aptinyx-raises-100-million-in-ipo?utm_source=BLOGS11&utm_medium=rss&utm_campaign=chicagobusiness
No comments:
Post a Comment